Rescue of interferon induced bone marrow aplasia in a patient with chronic myeloid leukemia by allogeneic bone marrow transplant

被引：6

作者：

Alabdulaaly, A

Rifkind, J

Solow, H

Messner, HA

Lipton, JH

机构：

[1] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Toronto, ON M5G 2M9, Canada

[2] Markham Stouffville Hosp, Markham, ON L3P 7P3, Canada

来源：

LEUKEMIA & LYMPHOMA | 2004年 / 45卷 / 01期

关键词：

CML; alpha interferon; aplasia; BMT;

D O I：

10.1080/1042819031000139774

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A patient with chronic phase Philadelphia chromosome positive CML, developed severe protracted bone marrow hypoplasia after interferon therapy. This complication did not respond to two courses of immunosuppressive therapy with anti-thymocyte globulin, cyclosporin A and prednisone. The patient continued to be transfusion dependent with persistence of Philadelphia chromosome. Allogeneic BMT restored normal hematopoeisis.

引用

页码：175 / 177

页数：3

共 21 条

[1] UK MEDICAL-RESEARCH-COUNCIL RANDOMIZED, MULTICENTER TRIAL OF INTERFERON-ALPHA-N1 FOR CHRONIC MYELOID-LEUKEMIA - IMPROVED SURVIVAL IRRESPECTIVE OF CYTOGENETIC RESPONSE
ALLAN, NC
RICHARDS, SM
SHEPHERD, PCA
[J]. LANCET, 1995, 345 (8962) : 1392 - 1397
[2] ANTILYMPHOCYTE GLOBULIN, CYCLOSPORINE, AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH ACQUIRED SEVERE APLASTIC-ANEMIA (SAA) - A PILOT-STUDY OF THE EBMT SAA WORKING PARTY
BACIGALUPO, A
BROCCIA, G
CORDA, G
ARCESE, W
CAROTENUTO, M
GALLAMINI, A
LOCATELLI, F
MORI, PG
SARACCO, P
TODESCHINI, G
COSER, P
IACOPINO, P
VANLINT, MT
GLUCKMAN, E
[J]. BLOOD, 1995, 85 (05) : 1348 - 1353
[3] INTERFERON-INDUCED CYTO-TOXICITY AND (2'-5') OLIGO(A) SYNTHETASE-ACTIVITY IN T-CELLS - DIFFERENCES IN RESPONSIVENESS AMONG T-CELLS FROM VARIOUS INDIVIDUALS AND AMONG LYMPHOBLASTOID T-CELL LINES
GAZITT, Y
BENBASSAT, H
WALLACH, D
REVEL, M
SCHATTNER, A
[J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1984, 30 (01): : 71 - 79
[4] Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia
Guilhot, F
Chastang, C
Michallet, M
Guerci, A
Harousseau, JL
Maloisel, F
Bouabdallah, R
Guyotat, D
Cheron, N
Nicolini, F
Abgrall, JF
Tanzer, J
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (04) : 223 - 229
[5] LEUKOCYTE INTERFERON-INDUCED TUMOR-REGRESSION IN HUMAN METASTATIC BREAST-CANCER, MULTIPLE-MYELOMA, AND MALIGNANT-LYMPHOMA
GUTTERMAN, JU
BLUMENSCHEIN, GR
ALEXANIAN, R
YAP, HY
BUZDAR, AU
CABANILLAS, F
HORTOBAGYI, GN
HERSH, EM
RASMUSSEN, SL
HARMON, M
KRAMER, M
PESTKA, S
[J]. ANNALS OF INTERNAL MEDICINE, 1980, 93 (03) : 399 - 406
[6] RECOMBINANT LEUKOCYTE-A INTERFERON - PHARMACOKINETICS, SINGLE-DOSE TOLERANCE, AND BIOLOGIC EFFECTS IN CANCER-PATIENTS
GUTTERMAN, JU
FINE, S
QUESADA, J
HORNING, SJ
LEVINE, JF
ALEXANIAN, R
BERNHARDT, L
KRAMER, M
SPIEGEL, H
COLBURN, W
TROWN, P
MERIGAN, T
DZIEWANOWSKI, Z
[J]. ANNALS OF INTERNAL MEDICINE, 1982, 96 (05) : 549 - 556
[7] INGIMARSSON S, 1980, ACTA MED SCAND, V208, P155
[8] SIDE-EFFECTS OF LONG-TERM TREATMENT WITH HUMAN-LEUKOCYTE INTERFERON
INGIMARSSON, S
CANTELL, K
STRANDER, H
[J]. JOURNAL OF INFECTIOUS DISEASES, 1979, 140 (04) : 560 - 563
[9] PROLONGED SURVIVAL IN CHRONIC MYELOGENOUS LEUKEMIA AFTER CYTOGENETIC RESPONSE TO INTERFERON-ALPHA THERAPY
KANTARJIAN, HM
SMITH, TL
OBRIEN, S
BERAN, M
PIERCE, S
TALPAZ, M
ROBERTSON, L
KOLLER, C
ESTEY, E
KEATING, MJ
[J]. ANNALS OF INTERNAL MEDICINE, 1995, 122 (04) : 254 - 261
[10] INTERFERON-INDUCED APLASIA - EVIDENCE FOR T-CELL-MEDIATED SUPPRESSION OF HEMATOPOIESIS AND RECOVERY AFTER TREATMENT WITH HORSE ANTIHUMAN THYMOCYTE GLOBULIN
MANGAN, KF
ZIDAR, B
SHADDUCK, RK
ZEIGLER, Z
WINKELSTEIN, A
[J]. AMERICAN JOURNAL OF HEMATOLOGY, 1985, 19 (04) : 401 - 413

← 1 2 3 →